Most Recent
IOOF chair told APRA conflicts of interest were ‘a bit of a non-event’
The former chairman of troubled IOOF told APRA during a review meeting that he "struggled" to think the wealth manager had any conflicts of interest and that the issue was getting too much "airplay", according to court documents filed recently by the prudential regulator.
Sanofi drops injector pen patent case against Alphapharm
After losing its fight for a temporary injunction, Sanofi-Aventis has dropped its patent lawsuit against Alphapharm over the generic drug maker's plans to market a competing insulin injector pen in Australia.
Engineering firm acquired by WorleyParsons sued over $132M arbitration award
The operator of a Vietnamese mine has filed a lawsuit seeking to enforce a $132 million arbitration judgment against  engineering company Jacobs E&C, which was acquired by WorleyParsons in December.
Jones Day nabs BHP’s top litigator for Melbourne office
Jones Day has bolstered its global disputes practice in Melbourne, bringing on experienced international dispute resolution lawyer Leah Ratcliff from BHP.
Otsuka can press ahead with ‘inconsistent’ defences in Abilify patent dispute
Otsuka Pharmaceuticals and Bristol Myers-Squibb can retain their defences in an ongoing patent dispute over antipsychotic drug Abilify, after the Federal Court dismissed a strike out bid by the Commonwealth of Australia over the allegedly "inconsistent" pleadings.
‘Misconceived’ Sanofi appeal over injector pen patent gets shot down by Full Court
The Full Court has denied a request by Sanofi that it review a judge's refusal to block Alphapharm from listing its Semglee insulin injector pen on the PBS, calling the pharmaceutical giant's appeal "misconceived".
Court to issue speedy ruling on Sanofi’s second stab at injector pen injunction
The Full Federal Court will issue its judgment Friday in French pharmaceutical giant Sanofi's challenge to a judge's refusal to block Alphapharm from listing an insulin injector pen on the PBS, just two weeks after the court heard arguments in the appeal.
Sanofi slams judge’s harm assessment in denying injector pen injunction
A judge that rejected a bid by Sanofi-Aventis for an injunction blocking rival Alphapharm from listing an insulin injector pen on the PBS erred in his consideration of the harm it would face, the drug giant has told the Full Federal Court.
Jones Day adds partner to Singapore arbitration group
An Australian partner of international law firm Jones Day has moved to the firm's Singapore office to bolster its growing team of international arbitration specialists.
Jones Day snags patent ace from Ashurst
International law firm Jones Day has expanded its intellectual property team in Sydney, hiring experienced patent litigator Andrew Rankine from Ashurst as its second local partner.